EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Non-Albuminuric Diabetic Kidney Disease: Pathophysiology and Clinical Implications

Eun Roh, Nan Hee Kim

Diabetes & Metabolism Journal · 01.11.2026 · 50 (6) · 1058-1069

DOI: 10.4093/dmj.2026.1009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.11.2026. Verfasst von Eun Roh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease traditionally progresses from glomerular hyperfiltration to albuminuria and kidney function loss. However, many individuals with type 2 diabetes mellitus develop reduced kidney function without increased urinary albumin excretion. This non-albuminuric phenotype accounts for approximately 20%–40% of diabetic kidney disease and 39%–55% of cases with reduced kidney function and is increasingly prevalent. Its emergence may reflect changes in disease biology and clinical management, including renin-angiotensin system blockade, improved cardiovascular risk factor control, and population aging. Histological, imaging, and biomarker studies suggest less prominent classic glomerular injury and greater contributions from intrarenal vascular disease, tubulointerstitial injury, and previous acute kidney injury. Kidney outcomes are generally more favorable than in albuminuric diabetic kidney disease, but associations with mortality remain inconsistent and may be influenced by coexisting cardiovascular disease. Treatment evidence is limited because most landmark kidney outcome trials preferentially enrolled patients with albuminuria, leaving uncertainty about optimal management. This review summarizes evidence on the epidemiology, pathophysiology, clinical characteristics, prognosis, and treatment of non-albuminuric diabetic kidney disease, highlighting its heterogeneity and clinical implications.

Zitieren

APA

Roh, E., & Kim, N. H. (2026). Non-Albuminuric Diabetic Kidney Disease: Pathophysiology and Clinical Implications. Diabetes & Metabolism Journal, 50(6), 1058-1069. https://doi.org/10.4093/dmj.2026.1009

Vancouver

Roh E, Kim NH. Non-Albuminuric Diabetic Kidney Disease: Pathophysiology and Clinical Implications. Diabetes & Metabolism Journal. 2026;50(6):1058-1069. doi:10.4093/dmj.2026.1009

BibTeX
@article{Roh2026,
  author = {Roh, Eun and Kim, Nan Hee},
  title = {Non-Albuminuric Diabetic Kidney Disease: Pathophysiology and Clinical Implications},
  journal = {Diabetes & Metabolism Journal},
  year = {2026},
  volume = {50},
  number = {6},
  pages = {1058--1069},
  doi = {10.4093/dmj.2026.1009}
}
Kostenlos starten →